Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.
about
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinomaSurgical Management of Local Recurrences of Renal Cell CarcinomaMetastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesNeoadjuvant therapy of renal cell carcinoma: a novel treatment option in the era of targeted therapy?Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma?Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkersSurgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinomaSurgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.Recent updates in renal cell carcinomaTargeted therapies in renal cell cancer: recent developments in imagingCombining targeted agents with modern radiotherapy in soft tissue sarcomas.The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors.Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib.Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma.Neo adjuvant treatment with targeted molecules for renal cell cancer in current clinical practise.Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trialMetastasectomy after targeted therapy in patients with advanced renal cell carcinoma.A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma.Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality?Long-term management of patients with metastatic renal cell carcinoma on targeted agents.Clinical guidance on the perioperative use of targeted agents in solid tumor oncology.Surgical management of large renal tumors.Optimizing treatment for metastatic renal cell carcinoma.Evidence-based clinical practice guideline for renal cell carcinoma: the Japanese Urological Association 2011 update.Neoadjuvant and adjuvant treatment of renal cell carcinoma.Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when.Impact of targeted neoadjuvant therapies in the treatment of solid organ tumours.Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.Do targeted agents offer clinical benefit as presurgical therapy?Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis.The role of metastasectomy in renal cell carcinoma.Cytoreductive nephrectomy: past, present and future.Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma.Landmarks in the diagnosis and treatment of renal cell carcinoma.Kidney cancer and 2014: is innovation really over?Role of targeted therapy in combination with surgery in renal cell carcinoma.
P2860
Q26749084-DC84CDCD-0B91-4BC5-99B3-340EC8DD4528Q26765579-5BF1A545-DAE7-4601-94DB-E38B16F8E364Q26852437-B8788CE2-0CCB-47E7-B630-E6C32653E14CQ27002583-BA2CFE46-E19B-4A61-AFF0-FD77DCDF6A38Q28087518-6B35F429-7409-4969-B6D9-CE9263137582Q30472042-7A37A8B4-8327-49F9-84C9-B2CDB315D5A8Q33740717-E523F016-78C0-4EC6-9F17-9107BC2AC1FDQ33754122-63BECCED-63E0-4056-A50E-3ED6A4B45707Q33843677-E73FEACE-EC14-4D0B-BEBD-46E00F6254C3Q33891216-9F071740-1335-4428-A5E0-3136F23A95D5Q34003369-FAF355FA-6B35-44EE-96D7-5DF4DFBFF2E4Q34088696-D24DCD27-6168-4410-A0C8-B4EBC804462BQ34396047-C3C0A521-E51C-4A17-B5B1-3F9BAC7E6C2EQ34501462-0726150C-A02F-4562-A5D7-01363B2E4003Q34572309-26BBE1E8-E7FC-4AB0-AD44-BC36CBAD7C99Q35230406-7B546CAB-5526-40D9-A8A6-A78921991C2AQ35413876-7A227A96-C3DF-4C2F-B628-2E0EADEBF973Q35660948-552E6A17-3621-4477-B43A-1BA3325B8919Q36084067-60BFEFD2-A315-4BFC-AD28-5741E27EBB50Q36338821-A55A8673-A99A-43DE-9308-A3C2F93397FDQ36344279-E4E14DAC-B4ED-4B61-83C5-A1E89F3A60B8Q37404963-34393F80-249C-4FDE-BED1-7E6EE8B3F1E7Q37772190-191C8DAA-E327-4F6B-ABCA-FEFD6C7615F1Q37812603-FD28C54D-088C-4A2C-AB11-2D9C6A9818DDQ37876494-2B09F1A4-7EEC-46BD-B450-B2B3BCCE549FQ37960913-EDEECEB6-34DC-4FCC-AB3A-E202BF368536Q37960915-0A6CABD5-62F8-46EA-8A65-63CA0CF763CCQ38012492-AB91BF03-AF38-4CFC-A0DB-95F41BD31BF6Q38020243-D25601D9-875A-480D-854D-0EA705540ED8Q38020245-7D7BD195-C80B-4371-ADB4-24CE76AF9A22Q38061098-20789186-C73A-47C2-8A37-B66DCC625405Q38068585-365D2E8B-0548-45D1-BC0C-30DC4492AAD9Q38084591-42C47C56-D49B-4080-B910-8325119DE597Q38103397-25AAF56F-EE77-484B-BA04-77B5EDC1355FQ38162921-26F5A375-5537-464C-A180-49B8E0C09B22Q38176034-4041D98D-D3EE-4327-A4F7-A0317E530719Q38188423-9B707644-B6CE-4BCA-BEAE-DD486F9EEF79Q38238966-B756E286-C2EB-4D7B-9D52-5491BB394CA8Q38465870-45560B23-60AA-428B-8FCF-7850E1111C16Q38560110-E94B6AB0-73E6-4576-9DFE-92D6B08271A3
P2860
Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Neoadjuvant clinical trial wit ...... r higher renal cell carcinoma.
@ast
Neoadjuvant clinical trial wit ...... r higher renal cell carcinoma.
@en
type
label
Neoadjuvant clinical trial wit ...... r higher renal cell carcinoma.
@ast
Neoadjuvant clinical trial wit ...... r higher renal cell carcinoma.
@en
prefLabel
Neoadjuvant clinical trial wit ...... r higher renal cell carcinoma.
@ast
Neoadjuvant clinical trial wit ...... r higher renal cell carcinoma.
@en
P2093
P2860
P356
P1476
Neoadjuvant clinical trial wit ...... r higher renal cell carcinoma.
@en
P2093
C Lance Cowey
Cathy Watkins
Chirag Amin
Dominic T Moore
Eric M Wallen
Gayle Grigson
Jeffrey Crane
Julia R Fielding
Keith V Nance
Mark Jalkut
P2860
P304
P356
10.1200/JCO.2009.24.7759
P407
P577
2010-02-16T00:00:00Z